“Epidemiology and Treatment of Older Adults with Inflammatory Bowel Disease”

Adam S. Faye, MD, an assistant professor of medicine and population health at the Division of Gastroenterology, NYU Grossman School of Medicine, recently delved into the epidemiology and treatment options for elderly patients with inflammatory bowel disease (IBS).

Dr. Faye’s research interests lie at the intersection of geriatrics and gastroenterology, with a particular focus on how biological markers can enhance risk assessment tools and clinical outcomes for older individuals with IBS.

According to Dr. Faye, there is a growing population of older adults experiencing inflammatory bowel disease. Additionally, there is a group of individuals who developed IBS at a younger age and are now aging, contributing to the rising number of older adults with the condition. He estimates that about 20% to 30% of individuals with IBS are over the age of 60.

While the exact causes of IBS remain unclear, Dr. Faye highlights the intricate interplay between genetic and environmental factors. Interestingly, older individuals with late-onset IBS are less likely to have a family history of the disease, suggesting a smaller genetic influence and a potentially larger environmental impact.

During the interview, Dr. Faye emphasized his dedication to studying this specific patient demographic and underscored the significance of mentorship in his career. He also highlighted the importance of collaborative efforts in conducting this research.

Dr. Faye expressed his enthusiasm for mentoring the next generation of researchers, emphasizing their vital role in continuing and advancing this line of research. His passion for supporting young minds in the medical field reflects his optimism for the future of inflammatory bowel disease research and treatment.